You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 218.7% |
| Latest | Forecast | |
|---|---|---|
| P/E | -26.1 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | -64.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -38.2% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | n/a | -8.63 | -9.50p | -22.9 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | n/a | -7.30 | -7.70p | -25.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -8.26 | -6.40p | -21.7 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -7.41 | -4.70p | -13.4 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -7.85 | -5.40p | -7.6 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.00 | -9.28 | -5.56p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 0.00 | -14.28 | -8.73p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Tiziana gets US patent for 'TZLS-501' antibody Sharecast News | 24 Aug |
|---|---|
| Tiziana gets US patent on use of 'Milciclib' Sharecast News | 21 Aug |
| Tiziana inks four deals for development of Covid-19 treatment Sharecast News | 04 Aug |
| Issue of Equity and Total Voting Rights | 21-Sep-20 07:04 |
|---|---|
| Clinical Study with Nasally Administered Foralumab | 17-Sep-20 07:04 |
| Second Price Monitoring Extn | 16-Sep-20 09:06 |
| Price Monitoring Extension | 16-Sep-20 09:01 |
| Demerger of StemPrintER and Distribution in Specie | 16-Sep-20 07:04 |